Brazilian pentavalent vaccine

Completed

• Conditions: Diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenzae type B diseases; Infections and Infestations; Bacterial infection of unspecified site

• Registration Number: ISRCTN95974322
• Lead Sponsor: Bio-Manguinhos/Fiocruz (Brazil)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-06-30
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

Healthy newborns (newborns and infants up to 7 months of age, of both sexes) whose parents/tutors understand the risk and benefits of the trial and agree to participate with written and informed consent.

Exclusion Criteria

Newborns or mothers:
1. Hepatitis B surface antigen (HBsAg) positive
2. Human immunodeficiency virus (HIV) seropositive
3. With positive serology for syphilis

Study & Design

• Study Type: Interventional
• Study Design: Not specified